27
https://pubmed.ncbi.nlm.nih.gov/38114725
This study constructed and validated a novel lysosomal signature for improved hepatocellular carcinoma prognosis, diagnosis, and personalized therapeutic decision-making, revealing its critical role in progression, tumor microenvironment regulation, and treatment response.